Clinical trials: Stage IV Renal Cell Cancer
- Condition Stage IV Renal Cell Cancer
- Funder type Industry (pharma, biotech, devices)
- Age group Children (under 18)
Kidney Cancer
Vaccine Therapy in Treating Patients With Kidney Cancer
RATIONALE: Vaccines made from a patient's white blood cells and tumor cells may make the body build an immune response to kill tumor cells.
- Trial name
- NCT00014131
- Testing
- Biological/Vaccine: therapeutic autologous dendritic cells.
- Where
- United States
- Volunteers
- 9 people
- Sponsor
- Lisata Therapeutics, Inc.